Facility Design Considerations

Instructor: John R Godshalk
Product ID: 701210
  • Duration: 45 Min

recorded version

$199.00 (87%)
Save $174.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Mar-2009

Training CD / USB Drive

$350.00 (57%)
Save $201.00
One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

In this General manufacturing training we will discuss Regulatory facility design considerations with guidelines and standards for successful facility design.

The overarching facility design considerations are discussed for the biologics industry. Regulatory facility design considerations are discussed with guidelines and standards for successful facility design. This is a high-level introduction to the regulatory requirements for facilities with an emphasis on GMP compliance for biologics facilities. Controlled manufacturing environments are discussed, including closed systems, clean room design, flow patterns, flexible spaces, lighting, and cleanroom surfaces.

Areas Covered in the seminar:

  • Required design elements for facilities.
  • FDA expectations for facility design.
  • Common errors and pitfalls in cleanroom design.
  • Industry standards for GMP spaces.
  • What FDA will typically inspect with respect to facilities.
  • Facility commissioning and validation.
  • Designing for good flow patterns.
  • Personnel Controls and GMP design.

Who will benefit:

  • QA managers and personnel
  • Regulatory Affairs personnel
  • Compliance managers and personnel
  • Project Managers

Instructor Profile:

John R Godshalk, currently works for the Biologics Consulting Group as a Senior Consultant. John served as a Senior Review Biochemical Engineer and Lead cGMP inspector in the Division of Manufacturing and Product Quality at CBER, FDA. He contributed to formulation of FDA policy as a member of the committee writing the Guidance Document for the Facilities and Controls for Cellular and Gene Therapy Manufacturing Operations. John has provided advice to industry on regulatory strategies, pharmaceutical product facility design, best practices, and validation approaches that meet FDA licensing requirements. John received his B.S. in chemical engineering from N.C. State University and his M.S.E. in biochemical engineering from Johns Hopkins University.

Follow us :
Seminars by Ex-FDA Officials
Upcoming In-person Seminars by EX-FDA OFFICIALS

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed